Defining an Obesity QTL on Chromosome 3q

Sponsor
Case Western Reserve University (Other)
Overall Status
Completed
CT.gov ID
NCT00087919
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
1,931
46

Study Details

Study Description

Brief Summary

To investigate the genetic basis of obesity by fine mapping an obesity quantitative trail linkage (QTL) linked to chromosome 3q.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    BACKGROUND:

    In the last several decades obesity has emerged as a major public health threat. While prevention through lifestyle change is the only long-term solution, better understanding of the physiologic mechanisms would greatly assist development of drugs and targeted prevention. Obesity is a highly heritable condition and while genes must account for a substantial proportion of individual susceptibility they have eluded detection. Powerful new genetic and genomic tools now permit comprehensive evaluation of candidate genes, including all genes under linkage peaks. These tools include new genomic resources (the human genome sequence, databases of common SNPs, and the haplotype map), rapid and inexpensive discovery and genotyping and new analytic methods (haplotype-based association and admixture mapping).

    DESIGN NARRATIVE:

    In a large African American family set Dr. Zhu and colleagues have obtained strong linkage evidence for obesity on chromosome 3q (combined LOD score = 3.7). A prime candidate (adiponectin) lies near this peak. They propose to follow up that finding by combining the epidemiologic data with high-throughput genotyping and move from linkage to association analysis. The results for this QTL will be evaluated within the available environmental factors to assess potential gene-environment and gene-gene interactions. The available phenotypes include body composition, resting metabolic rate, physical activity, plasma insulin, glucose, and leptin. In a family-based design they will examine the linkage peak centered on position 188 cM on chromosome 3q (20 Cm 1-LOD support interval), with the following step-wise strategy: (a) Genotype 200 single nucleotide polymorphisms (SNPs) in this region on 300 families (1,000 individuals); (b) Conduct linkage, linkage disequilibrium and admixture mapping to potentially further narrow the region; and (c) Conduct resequencing and haplotype-based association studies for all candidate genes under the peak. Statistical analysis incorporating intermediate phenotypes and environmental covariates will be used to characterize potential gene x gene or gene x environment interactions. Replication will be tested in additional populations of African and European origin.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1931 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Study Start Date :
    Jul 1, 2004
    Actual Primary Completion Date :
    May 1, 2008
    Actual Study Completion Date :
    May 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    Maywood

    The were 743 subjects were sampled from Maywood, Il. There was no intervention.

    Nigeria

    There were 1188 Nigerian sampled from Igbo-Ora and Ibadan, Nigeria. There was no intervention.

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 74 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes

      The survey enrolled a representative random sample of the population the age of 18 and 74, regardless of obesity phenotype.

      Contacts and Locations

      Locations

      No locations specified.

      Sponsors and Collaborators

      • Case Western Reserve University
      • National Heart, Lung, and Blood Institute (NHLBI)

      Investigators

      • Principal Investigator: Xiaofeng Zhu, Case Western Reserve University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Case Western Reserve University
      ClinicalTrials.gov Identifier:
      NCT00087919
      Other Study ID Numbers:
      • 1263
      • R01HL074166
      First Posted:
      Jul 19, 2004
      Last Update Posted:
      Feb 23, 2022
      Last Verified:
      Jul 1, 2008
      Studies a U.S. FDA-regulated Drug Product:
      No
      Studies a U.S. FDA-regulated Device Product:
      No
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 23, 2022